A randomized, controlled, feasibility study of RD‐X19 in subjects with mild‐to‐moderate COVID‐19 in the outpatient setting

A randomized, controlled, feasibility study of RD‐X19 in subjects with mild‐to‐moderate COVID‐19 in the outpatient setting

Abstract The RD‐X19 is an investigational, handheld medical device precisely engineered to emit blue light through the oral cavity to target the oropharynx and surrounding tissues. At doses shown to be noncytotoxic in an in vitro three‐dimensional human epithelial tissue model, the monochromatic vis...

Full description

Bibliographic Details
Main Authors: Nathan Stasko, Adam S. Cockrell, Jacob F. Kocher, Ibrahim Henson, David Emerson, Ye Wang, Jonathan R. Smith, Nathan H. Henderson, Hillary Wood, Shelton S. Bradrick, Terry Jones, Jorge Santander, John G. McNeil
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13249

Internet

https://doi.org/10.1111/cts.13249

Similar Items